European Non-Invasive Trisomy Evaluation (EU-NITE) study: A multicenter prospective cohort study for non-invasive fetal trisomy 21 testing

Prenatal Diagnosis

Volumn 33, Issue 10, 2013, Pages 996-1001

  Verweij, E J ^a   Jacobsson, B ^b   van Scheltema, P A ^a   de Boer, M A ^a   Hoffer, M J V ^a   Hollemon, D ^c   Westgren, M ^d   Song, K ^c   Oepkes, D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Ariosa Diagnostics   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME 21; CHROMOSOME ANALYSIS; COHORT ANALYSIS; FALSE NEGATIVE RESULT; FEMALE; FETUS; FETUS KARYOTYPING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; NON INVASIVE PROCEDURE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SHIPPING; STANDARD; SWEDEN; TRISOMY 21;

ADULT; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; DOWN SYNDROME; EUROPE; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TRISOMY; YOUNG ADULT;

EID: 84884982181     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4182     Document Type: Article

References (18)

1. Boyd PA, Devigan C, Khoshnood B, et al. EUROCAT working group. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and down's syndrome. BJOG 2008;115:689-96.
2. Ekelund CK, Petersen OB, Skibsted L. et al. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ultrasound Obstet Gynecol 2011;38:140-4.
3. Van den Berg M, Timmermans DR, Garcia E, et al. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons. Prenat Diagn 2005;25:84-90.
4. Borrell A, Casals E, Fortuny A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004;24:541-5.
5. Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-24.
6. Berktold L, Kaisenberg C, Hillemanns P, et al. Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening. Arch Gynecol Obstet 2013;287:413-20.
7. Muñoz-Cortes M, Arigita M, Falguera G, et al. Contingent screening for Down syndrome completed in the first trimester: a multicenter study. Ultrasound Obstet Gynecol 2012;39:396-400.
8. Sainz JA, Serrano R, Borrero C, et al. First trimester contingent test as a screening method for Down's syndrome. A prospective study in the general population. J Matern Fetal Neonatal Med 2012;25:2221-4.
9. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;16:483-7.
10. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
11. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225-32.
12. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:322.
13. Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.
14. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32:319.
15. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.
16. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.
17. Steel RGD, Torrie JH, Dickey DA. Principles and Procedures of Statistics. New York: A Biomedical Approach. The McGraw-Hill Companies, Inc, 1997;558.
18. Hill M, Fisher J, Chitty LS, et al. Women's and health professionals' preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genet Med 2012;14:905-13.